Assyro AI
FDA Orange Book · active-ingredient family

Chlorhexidine gluconate

Chlorhexidine gluconate: 16 brands, 16 generics; first approved Dec 24, 1984; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available — 16 ANDA applications approved.

Earliest patent expiry Apr 25, 2026
Brands (NDA)
16
Generics (ANDA)
16
Listed patents
2
Next patent expiry
Apr 25, 2026
3 mo ago
Originator applications

Brand (NDA) products

NDA 2079642018
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
2%CLOTHTOPICALOTC
NDA 0216692005
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
2%CLOTHTOPICALOTC
NDA 0207741998
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
2.5MGTABLETDENTALDiscontinued
PERIDEXRLDRS
NDA 0190281986
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALRxAT
NDA 0194221985
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
2%SOLUTIONTOPICALOTC
EXIDINERLDRS
NDA 0191271984
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%AEROSOL, METEREDTOPICALOTC
NDA 017768
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SOLUTIONTOPICALOTC
NDA 018300
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.5%SOLUTIONTOPICALOTC
NDA 018423
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SPONGETOPICALDiscontinued
NDA 0201111997
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.75%SOLUTIONTOPICALOTC
NDA 0198221989
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SPONGETOPICALOTC
NDA 0197931988
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SPONGETOPICALDiscontinued
NDA 0194901987
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SPONGETOPICALDiscontinued
NDA 01925819862 strengths
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
2%SOLUTIONTOPICALOTC
4%SOLUTIONTOPICALOTC
NDA 0194211985
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
2.5%SOLUTIONTOPICALDiscontinued
NDA 0191251984
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SOLUTIONTOPICALOTC
Abbreviated applications

Generic (ANDA) products (16)

ANDA 2032122016
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALRxAT
ANDA 0777892009
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALRxAT
ANDA 0764342005
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALDiscontinued
ANDA 0750062004
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALRxAT
ANDA 0755612000
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALRxAT
ANDA 0734162000
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SPONGETOPICALDiscontinued
ANDA 0743561996
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALDiscontinued
ANDA 0742911995
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALRxAT
ANDA 0745221995
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALRxAT
ANDA 0736951994
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.12%SOLUTIONDENTALDiscontinued
ANDA 0722921992
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
0.5%SOLUTIONTOPICALDiscontinued
ANDA 0722551991
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SOLUTIONTOPICALDiscontinued
ANDA 0722951991
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SPONGETOPICALDiscontinued
ANDA 0725251989
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SPONGETOPICALOTC
ANDA 0714191987
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SOLUTIONTOPICALDiscontinued
ANDA 0701041986
Approved strengths under this FDA application.
StrengthDosage formRouteStatusTE
4%SOLUTIONTOPICALDiscontinued
Protection horizon

Patent & exclusivity timeline

202620272028TodayPatent 7427574 — 2026-04-25Patent 7427574Patent 7935093 — 2027-10-02Patent 7935093
Patent expiryExclusivity endToday
Orange Book patent file

Listed patents

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7427574Apr 25, 20263 mo ago
Product
7935093Oct 02, 2027in 1 yr 3 mo
ProductU-1022
FDA approval span

Approval history

First approval
Dec 24, 1984
42 yr 2 mo ago
Most recent approval
Nov 20, 2018
7 yr 9 mo ago

Approvals span 1984–2018 across 32 FDA applications.

Brand (NDA) 1650%
Generic (ANDA) 1650%

Chlorhexidine gluconate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.